Anixa Biosciences Inc
ANIX
Revenue
210.00k
▼-303.00k▼-59.06%
15 Months ChangeAssets
22.91M
▼-1.45M▼-5.94%
3 Months ChangeLiabilities
2.22M
▲443.00k▲24.97%
3 Months ChangeFree Cash Flow
-1.93M
▼-587.70k▼-43.78%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-06
Form 10-Q
ID: 0001493152-24-035335
2024-06-04
Form 10-Q
ID: 0001493152-24-022573
2024-05-08
Form 8-K
ID: 0001493152-24-018170
2024-03-22
Form 8-K
ID: 0001493152-24-010995
2024-03-12
Form 10-Q
ID: 0001493152-24-009683
2023-12-07
Form 8-K
ID: 0001493152-23-043932
2023-09-06
Form 10-Q
ID: 0001493152-23-031826
2023-06-14
Form 10-Q
ID: 0001493152-23-021271
2023-04-17
Form 8-K
ID: 0001493152-23-012483
2023-03-17
Form 10-Q
ID: 0001493152-23-007994